Stable earnings through an optimal product mix across direct sales, OEM and contract manufacturing
First written in FY2018. 14 of 30 entries say "Advanced", first in FY2019-Q1. Latest entry: 2026-08-10.
Chemipro Kasei moved to the "Worse" side of this theme in 2026.
0 other companies' latest entry also says "Worsened".
- 2026-08-10WorsenedEarnings
「Contract manufacturing products decreased by ¥49 million to ¥539 million, down 8.4%.」
First-quarter sales of contract manufacturing products declined 8.4% year on year. - FY2026Decline in Contract Manufacturing RevenueAnnual report
「Contract-manufactured products decreased by ¥192 million to ¥2,172 million, down 8.2% year on year, while」
While aiming for stable earnings through an optimal product mix of direct sales, OEM and contract manufacturing, the Company’s contract-manufactured products recorded an 8.2% full-year decline in revenue. - FY2026-H1Decline in Contract Manufacturing RevenueAnnual report
「Contract-manufactured products decreased by ¥95 million to ¥988 million, down 8.8% year on year」
First-half revenue from contract-manufactured products was ¥988 million, down 8.8% year on year. The contract manufacturing business reported lower revenue, despite the goal of securing stable earnings through an optimal product mix of direct sales, OEM and contract manufacturing. - FY2025AdvancedAnnual report
「Contract-manufactured products increased by ¥232 million to ¥2,365 million, up 10.9% year on year」
Full-year revenue from contract-manufactured products was ¥2,365 million, up 10.9% year on year, marking progress toward securing stable earnings through an optimal product mix of direct sales, OEM and contract manufacturing. - FY2025-H1Decline in Contract Manufacturing RevenueAnnual report
「Contract-manufactured products decreased by ¥60 million to ¥1,083 million, down 5.3% year on year」
First-half revenue from contract-manufactured products was ¥1,083 million, down 5.3% year on year. - FY2024-Q3AdvancedAnnual report
「Contract-manufactured products increased by ¥48 million to ¥1,617 million, up 3.1% year on year」
Cumulative third-quarter revenue from contract-manufactured products was ¥1,617 million, up 3.1% year on year. - FY2024-Q2Slight decline in contract manufacturing revenueAnnual report
「Contract-manufactured products decreased by ¥11 million to ¥1,143 million, down 1.0% year on year」
Cumulative second-quarter revenue from contract-manufactured products was ¥1,143 million, down 1.0% year on year. Revenue turned to a slight decline after increasing through the previous period. - FY2024-Q1Decline in Contract Manufacturing RevenueAnnual report
「Contract-manufactured products decreased by ¥96 million to ¥401 million, down 19.3% year on year」
Cumulative first-quarter revenue from contract-manufactured products was ¥401 million, down 19.3% year on year. Performance turned to a decline, against the goal of securing stable earnings through an optimal product mix that includes contract manufacturing. - FY2023AdvancedAnnual report
「Contract-manufactured products increased by ¥211 million to ¥2,005 million, up 11.8% year on year」
Full-year revenue from contract-manufactured products was ¥2,005 million, up 11.8% year on year. The contract manufacturing business showed numerical progress toward securing stable earnings through an optimal product mix of direct sales, OEM and contract manufacturing. - FY2023-Q3AdvancedAnnual report
「Contract-manufactured products increased by ¥269 million to ¥1,569 million, up 20.7% year on year」
Cumulative third-quarter revenue from contract-manufactured products was ¥1,569 million, up 20.7% year on year. - FY2023-Q2AdvancedAnnual report
「Contract-manufactured products increased by ¥224 million to ¥1,155 million, up 24.1% year on year」
Cumulative second-quarter revenue from contract-manufactured products was ¥1,155 million, up 24.1% year on year. - FY2023-Q1AdvancedAnnual report
「In the cumulative first quarter, revenue increased by ¥320 million year on year to ¥1,552 million, up 26.0%, for ultraviolet absorbers, the Company’s core products, while contract-manufactured products increased by ¥47 million to ¥497 million, up 10.5%.」
Revenue from contract-manufactured products was ¥497 million, up 10.5% year on year. This represented numerical progress toward securing stable earnings through a product mix that includes contract manufacturing. - FY2022Decline in contract manufacturing revenue under the revenue recognition standardAnnual report
「Contract-manufactured products decreased by ¥329 million to ¥1,794 million, down 15.5% year on year, while total revenue increased by ¥230 million to ¥8,762 million, up 2.7%. However, the revenue from contract-manufactured products reflects a ¥817 million decrease due to the adoption of the revenue recognition accounting standard and other related standards.」
Reported revenue from contract-manufactured products decreased 15.5% year on year, but includes a ¥817 million decrease due to the adoption of the revenue recognition accounting standard. The Chemicals business as a whole reported higher revenue. - FY2022-Q3Decline in contract manufacturing revenue under the revenue recognition standardAnnual report
「Contract-manufactured products decreased by ¥272 million to ¥1,300 million, down 17.3% year on year, while total revenue increased by ¥355 million to ¥6,443 million, up 5.8%. However, the revenue from contract-manufactured products reflects a ¥378 million decrease due to the adoption of the revenue recognition accounting standard and other related standards.」
Reported revenue from contract-manufactured products decreased 17.3% year on year, but includes a ¥378 million decrease due to the adoption of the revenue recognition accounting standard. The Chemicals business as a whole reported a 5.8% increase in revenue. - FY2022-Q2Decline in contract manufacturing revenue due to adoption of the revenue recognition standardAnnual report
「Contract-manufactured products decreased by ¥25 million to ¥930 million, down 2.6% year on year, while total revenue increased by ¥587 million to ¥4,242 million, up 16.1%. However, the revenue from contract-manufactured products reflects a ¥204 million decrease due to the adoption of the revenue recognition accounting standard and other related standards.」
Reported revenue from contract-manufactured products decreased 2.6%, but includes a ¥204 million decrease due to the adoption of the revenue recognition accounting standard. The Chemicals business as a whole reported a 16.1% increase in revenue. - FY2022-Q1AdvancedAnnual report
「Contract-manufactured products increased by ¥13 million to ¥450 million, up 3.0% year on year」
Cumulative first-quarter revenue from contract-manufactured products was ¥450 million, up 3.0% year on year. - FY2021AdvancedAnnual report
「Contract-manufactured products increased by ¥214 million to ¥2,123 million, up 11.2% year on year」
Full-year revenue from contract-manufactured products was ¥2,123 million, up 11.2% year on year. The contract manufacturing business showed numerical progress toward securing stable earnings through an optimal product mix of direct sales, OEM and contract manufacturing. - FY2021-Q3AdvancedAnnual report
「Contract-manufactured products increased by ¥348 million to ¥1,573 million, up 28.5% year on year, although total revenue settled at ¥6,087 million, down ¥682 million, or 10.1%, year on year.」
Contract-manufactured products, one means of securing stable earnings through an optimal product mix of direct sales, OEM and contract manufacturing, recorded a 28.5% year-on-year increase in revenue. - FY2021-Q2AdvancedAnnual report
「Contract-manufactured products increased by ¥161 million to ¥955 million, up 20.3% year on year, although」
Cumulative second-quarter revenue from contract-manufactured products was ¥955 million, up 20.3% year on year. - FY2021-Q1Slight decline in contract manufacturingAnnual report
「Contract-manufactured products decreased by ¥3 million to ¥436 million, down 0.7% year on year」
Revenue from contract-manufactured products was ¥436 million, down 0.7% year on year. - FY2020Decline in Contract Manufacturing RevenueAnnual report
「Contract-manufactured products also recorded lower revenue, although new products offset some of the decline in demand for certain items.」
Revenue from contract-manufactured products was ¥1,909 million, down ¥43 million, or 2.2%, year on year. Although new products offset part of the decline, challenges remain in achieving stable earnings through an optimal product mix. - FY2020-Q3Decline in Contract Manufacturing RevenueAnnual report
「The increase of ¥703 million in total revenue to ¥6,770 million, up 11.6% year on year, offset the ¥277 million decline in contract-manufactured products to ¥1,224 million, down 18.5%.」
Revenue from contract-manufactured products decreased 18.5% year on year, continuing the decline after the previous quarter’s revenue growth. The Chemicals business as a whole reported higher revenue due to increased revenue from other products. - FY2020-Q2Decline in Contract Manufacturing RevenueAnnual report
「The increase of ¥329 million in total revenue to ¥4,540 million, up 7.8% year on year, offset the declines in contract-manufactured products, which fell by ¥190 million to ¥794 million, down 19.3%, photographic chemical intermediates, which fell by ¥50 million to ¥130 million, down 28.0%, and antioxidants, which fell by ¥40 million to ¥175 million, down 18.7%.」
Revenue from contract-manufactured products decreased 19.3% year on year. Although the Chemicals business as a whole reported higher revenue, the contract manufacturing business turned to a decline from the revenue growth recorded through the previous quarter. - FY2020-Q1AdvancedAnnual report
「Contract-manufactured products increased by ¥42 million to ¥440 million, up 10.7% year on year」
Revenue from contract-manufactured products increased 10.7% year on year, indicating progress in the performance of the contract manufacturing business. - FY2019-Q3AdvancedAnnual report
「Other, including contract-manufactured products, increased by ¥343 million to ¥1,569 million, up 28.0% year on year」
Revenue from Other, including contract-manufactured products, increased 28.0% year on year, indicating progress in the performance of the contract manufacturing business. - FY2019-Q2AdvancedAnnual report
「Other, including contract-manufactured products, increased by ¥199 million to ¥1,025 million, up 24.1% year on year」
Revenue from Other, including contract-manufactured products, increased 24.1% year on year, indicating progress in the performance of the contract manufacturing business. - FY2019-Q1AdvancedAnnual report
「Other, including contract-manufactured products, increased by ¥98 million to ¥417 million, up 30.9% year on year」
Revenue from Other, including contract-manufactured products, increased 30.9% year on year, indicating progress in the performance of the contract manufacturing business. - FY2018First statedAnnual report
「Securing stable earnings through an optimal product mix of direct sales, OEM and contract manufacturing」
The Company aims to secure stable earnings through an optimal product and sales mix combining direct sales, OEM and contract manufacturing. In contract manufacturing, it has also identified strengthening relationships with existing customers, developing new customers and using external organizations as initiatives.